Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Rivera-Oyola

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the American Academy of Dermatology|August 1, 2020
Reply to research letterRyan Rivera-Oyola, Merav Koschitzky, Mark Lebwohl
The Journal of Clinical and Aesthetic Dermatology|May 31, 2021
The Psoriasis Decision TreeGeorge Monks, Ryan Rivera-Oyola, Mark Lebwohl
Journal of the American Academy of Dermatology|April 14, 2020
Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution"Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell
Journal of the American Academy of Dermatology|March 23, 2020
Should biologics for psoriasis be interrupted in the era of COVID-19?Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell
Journal of the American Academy of Dermatology|April 14, 2020
Reply to: "Biologics for psoriasis during COVID-19 outbreak"Dedee F Murrell, Ryan Rivera-Oyola, Mark Lebwohl
International Journal of Dermatology|March 2, 2021
Durable remissions of guttate psoriasis following short courses of IL-17 inhibitorsRachel Printy, Ryan Rivera-Oyola, Annette Czernik, et al.
Lasers in Surgery and Medicine|May 14, 2024
Intraoral laser hair removal: A scoping reviewAbigail Katz, Ryan Rivera-Oyola, Carrie Levinson, et al.
Clinics in Dermatology|May 11, 2021
Pediatric COVID toes and fingersMerav Koschitzky, Ryan Rivera Oyola, Mary Lee-Wong, et al.
JAAD Case Reports|April 26, 2021
Eczematous reactions to psoriasis biologics treated with dupilumab: A case seriesMerav Koschitzky, Kathryn Tan, Maria Rosa Noliza Encarnacion, et al.
International Journal of Dermatology|October 21, 2020
Treatment of COVID-19 induced chilblains with topical nitroglycerinMark Weingarten, Brian Abittan, Ryan Rivera-Oyola, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the American Academy of Dermatology|August 1, 2020
Reply to research letterRyan Rivera-Oyola, Merav Koschitzky, Mark Lebwohl
The Journal of Clinical and Aesthetic Dermatology|May 31, 2021
The Psoriasis Decision TreeGeorge Monks, Ryan Rivera-Oyola, Mark Lebwohl
Journal of the American Academy of Dermatology|April 14, 2020
Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution"Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell
Journal of the American Academy of Dermatology|March 23, 2020
Should biologics for psoriasis be interrupted in the era of COVID-19?Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell
Journal of the American Academy of Dermatology|April 14, 2020
Reply to: "Biologics for psoriasis during COVID-19 outbreak"Dedee F Murrell, Ryan Rivera-Oyola, Mark Lebwohl
International Journal of Dermatology|March 2, 2021
Durable remissions of guttate psoriasis following short courses of IL-17 inhibitorsRachel Printy, Ryan Rivera-Oyola, Annette Czernik, et al.
Lasers in Surgery and Medicine|May 14, 2024
Intraoral laser hair removal: A scoping reviewAbigail Katz, Ryan Rivera-Oyola, Carrie Levinson, et al.
Clinics in Dermatology|May 11, 2021
Pediatric COVID toes and fingersMerav Koschitzky, Ryan Rivera Oyola, Mary Lee-Wong, et al.
JAAD Case Reports|April 26, 2021
Eczematous reactions to psoriasis biologics treated with dupilumab: A case seriesMerav Koschitzky, Kathryn Tan, Maria Rosa Noliza Encarnacion, et al.
International Journal of Dermatology|October 21, 2020
Treatment of COVID-19 induced chilblains with topical nitroglycerinMark Weingarten, Brian Abittan, Ryan Rivera-Oyola, et al.
Pageof 2